Home/ Supplements/ Vitamin K/ Heart Artery & Vein Health

Heart Artery & Vein Health

product on market Capsule Emerald Labs Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains Vitamin K2 and tocotrienols, which have moderate evidence for supporting cardiovascular health and arterial function. Garlic and hawthorne berry are traditionally used for heart health, though clinical evidence for their efficacy in this specific combination is limited. The profile maintains a high safety rating with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Heart Artery & Vein Health
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

10 mcg (8% DV)
Within RDA (0.1× RDA) 275 studies (A:9, B:175)
25 mg
1.7× RDA — within safe limits 179 studies (A:3, B:90)
Market median: 250.0mg (182 products) 10 studies (A:0, B:2)
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
Market median: 333.0mg (166 products) 9 studies (A:0, B:2)
Meriva
100 mg
Market median: 260.0mg (249 products) 158 studies (A:4, B:61)
Cayenne, Powder
200 mg
Raw Whole-Food Proprietary Blend
160 mg

Other Ingredients

Capsule
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Adults, take three (3) capsules divided throughout the day with or without food.

Warnings & Precautions

Product is manufactured in a facility that processes milk, egg, soy, tree nuts, fish and shellfish.

Keep out of reach of children.

Do not use if safety seal is on cap or printed inner seal is missing or broken.

Consult a physician if pregnant, lactating, currently on prescription medication or diagnosed with a medical condition.

Formulation Notes

Heart Health contains therapeutic amounts of synergistic nutrients that have been shown to help support overall heart health.

We are committed to providing your family with additive-free formulas and superior nutrient forms in therapeutic amounts. This product is free of: Corn, milk, salt, yeast, soy, added sugar, wheat, artificial flavors and preservatives.

Doctor-Formulated

Meriva curcuminoids 99% Delta tocotrienols European Hawthorne Berry

Clinical Potency

Made with Non-GMO Ingredients No Magnesium Stearate Gluten-Free

Vegan Formula

Raw Whole-Food Based

Additional Information

Emerald Labs is family owned and operated since our beginnings in 1996.

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU7 43650 00226 9
DSLD Entry Date2024-01-24
Product TypeOther Combinations
FormCapsule
DSLD ID302616
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.